Table 5.
FVC impairment | FEV1 impairment | |||||||
---|---|---|---|---|---|---|---|---|
Men | Women | Men | Women | |||||
OR | P value | OR | P value | OR | P value | OR | P value | |
Model 1 | 1.114 (1.008–1.231) | P = 0.034 | 1.230 (1.147–1.319) | P < 0.001 | 1.054 (0.952–1.167) | P = 0.313 | 1.167 (1.082–1.258) | P < 0.001 |
Model 2 | 1.168 (1.05–1.299) | P = 0.004 | 1.218 (1.134–1.307) | P < 0.001 | 1.097 (0.984–1.222) | P = 0.094 | 1.160 (1.075–1.252) | P < 0.001 |
Model 3 | 1.122 (1.000–1.259) | P = 0.050 | 1.164 (1.078–1.256) | P < 0.001 | 1.074 (0.956–1.206) | P = 0.229 | 1.154 (1.062–1.254) | P = 0.001 |
Model 1 is unadjusted; Model 2 is adjusted for age, education, smoking and drinking; Model 3 is adjusted for age, education, smoking, drinking, SBP, DBP, FPG, TC, uric acid, and eGFR
FVC forced vital capacity, FEV1 forced expiratory volume in 1 s, SBP systolic blood pressure, DBP diastolic blood pressure, FPG fasting plasma glucose, TC total cholesterol, eGFR estimated glomerular filtration rate